Autolus Therapeutics Announces Publication in Molecular Therapy
- Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR - AUTO1/22 may reduce CD19 negative escape in children with B-ALL, and may have broader applications in... | April 4, 2023
Source: marketscreener.com